These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 29164800)

  • 1. The Generation of Human γδT Cell-Derived Induced Pluripotent Stem Cells from Whole Peripheral Blood Mononuclear Cell Culture.
    Watanabe D; Koyanagi-Aoi M; Taniguchi-Ikeda M; Yoshida Y; Azuma T; Aoi T
    Stem Cells Transl Med; 2018 Jan; 7(1):34-44. PubMed ID: 29164800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human iPSC Generation from Antigen-Specific T Cells.
    Nishimura T; Murmann Y; Nakauchi H
    Methods Mol Biol; 2019; 2048():53-57. PubMed ID: 31396928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient Generation of Non-Integration and Feeder-Free Induced Pluripotent Stem Cells from Human Peripheral Blood Cells by Sendai Virus.
    Ye H; Wang Q
    Cell Physiol Biochem; 2018; 50(4):1318-1331. PubMed ID: 30355953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-generation of cytotoxic γδT cells with distinctive signatures from human γδT-derived iPSCs.
    Murai N; Koyanagi-Aoi M; Terashi H; Aoi T
    Stem Cell Reports; 2023 Apr; 18(4):853-868. PubMed ID: 36963392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic human peripheral blood-derived γδT cells kill glioblastoma cell lines: implications for cell-based immunotherapy for patients with glioblastoma.
    Nakazawa T; Nakamura M; Park YS; Motoyama Y; Hironaka Y; Nishimura F; Nakagawa I; Yamada S; Matsuda R; Tamura K; Sugimoto T; Takeshima Y; Marutani A; Tsujimura T; Ouji N; Ouji Y; Yoshikawa M; Nakase H
    J Neurooncol; 2014 Jan; 116(1):31-9. PubMed ID: 24062140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dichotomous and stable gamma delta T-cell number and function in healthy individuals.
    Ou L; Wang H; Liu Q; Zhang J; Lu H; Luo L; Shi C; Lin S; Dong L; Guo Y; Huang L; Zhu J; Yin X; Huang AC; Karakousis G; Schuchter L; Amaravadi R; Zheng C; Fan Y; Guo W; Xu X
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34011536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of γδT cells from HSC-enriched BMCs co-cultured with iPSC-derived thymic epithelial cells.
    Hosaka N; Kanda S; Shimono T; Nishiyama T
    J Cell Mol Med; 2021 Nov; 25(22):10604-10613. PubMed ID: 34687276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
    Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα.
    Bueno C; Sardina JL; Di Stefano B; Romero-Moya D; Muñoz-López A; Ariza L; Chillón MC; Balanzategui A; Castaño J; Herreros A; Fraga MF; Fernández A; Granada I; Quintana-Bustamante O; Segovia JC; Nishimura K; Ohtaka M; Nakanishi M; Graf T; Menendez P
    Leukemia; 2016 Mar; 30(3):674-82. PubMed ID: 26500142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgene-free iPSCs generated from small volume peripheral blood nonmobilized CD34+ cells.
    Merling RK; Sweeney CL; Choi U; De Ravin SS; Myers TG; Otaizo-Carrasquero F; Pan J; Linton G; Chen L; Koontz S; Theobald NL; Malech HL
    Blood; 2013 Apr; 121(14):e98-107. PubMed ID: 23386128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of induced pluripotent stem cell (iPSC) from NY-ESO-I-specific cytotoxic T cells isolated from the melanoma patient with minor HLAs: The practical pilot study for the adoptive immunotherapy for melanoma using iPSC technology.
    Itoh M; Kawagoe S; Nakagawa H; Asahina A; Okano HJ
    Exp Dermatol; 2023 Feb; 32(2):126-134. PubMed ID: 36222007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of Patient-Specific induced Pluripotent Stem Cell from Peripheral Blood Mononuclear Cells by Sendai Reprogramming Vectors.
    Quintana-Bustamante O; Segovia JC
    Methods Mol Biol; 2016; 1353():1-11. PubMed ID: 25523810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New type of Sendai virus vector provides transgene-free iPS cells derived from chimpanzee blood.
    Fujie Y; Fusaki N; Katayama T; Hamasaki M; Soejima Y; Soga M; Ban H; Hasegawa M; Yamashita S; Kimura S; Suzuki S; Matsuzawa T; Akari H; Era T
    PLoS One; 2014; 9(12):e113052. PubMed ID: 25479600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of Antigen-Specific T Cells from Human Induced Pluripotent Stem Cells.
    Nishimura T; Nakauchi H
    Methods Mol Biol; 2019; 1899():25-40. PubMed ID: 30649763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood cell-derived induced pluripotent stem cells free of reprogramming factors generated by Sendai viral vectors.
    Ye L; Muench MO; Fusaki N; Beyer AI; Wang J; Qi Z; Yu J; Kan YW
    Stem Cells Transl Med; 2013 Aug; 2(8):558-66. PubMed ID: 23847002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo programming of tumor antigen-specific T lymphocytes from pluripotent stem cells to promote cancer immunosurveillance.
    Lei F; Zhao B; Haque R; Xiong X; Budgeon L; Christensen ND; Wu Y; Song J
    Cancer Res; 2011 Jul; 71(14):4742-7. PubMed ID: 21628492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells.
    Hu K; Yu J; Suknuntha K; Tian S; Montgomery K; Choi KD; Stewart R; Thomson JA; Slukvin II
    Blood; 2011 Apr; 117(14):e109-19. PubMed ID: 21296996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-transmissible MV Vector with Segmented RNA Genome Establishes Different Types of iPSCs from Hematopoietic Cells.
    Hiramoto T; Tahara M; Liao J; Soda Y; Miura Y; Kurita R; Hamana H; Inoue K; Kohara H; Miyamoto S; Hijikata Y; Okano S; Yamaguchi Y; Oda Y; Ichiyanagi K; Toh H; Sasaki H; Kishi H; Ryo A; Muraguchi A; Takeda M; Tani K
    Mol Ther; 2020 Jan; 28(1):129-141. PubMed ID: 31677955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reprogramming of Primary Human Cells to Induced Pluripotent Stem Cells Using Sendai Virus.
    Draper JM; Vivian JL
    Methods Mol Biol; 2020; 2066():217-234. PubMed ID: 31512220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of highly proliferative, rejuvenated cytotoxic T cell clones through pluripotency reprogramming for adoptive immunotherapy.
    Kawai Y; Kawana-Tachikawa A; Kitayama S; Ueda T; Miki S; Watanabe A; Kaneko S
    Mol Ther; 2021 Oct; 29(10):3027-3041. PubMed ID: 34023508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.